Emergent BioSolutions Inc.

NYSE:EBS

Pharmaceutical Preparations·GAITHERSBURG, MD

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland.

CEO

Papa Joseph C

CFO

Lindahl Richard S

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/27/26	→
10-Q	Q3 2025	9/30/25	10/30/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/4/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

18 shown

Filed	Period
2/26/26	Q1 FY2026	→
10/29/25	Q3 FY2025	→
8/6/25	Q3 FY2025	→
5/7/25	Q2 FY2025	→
3/3/25	Q1 FY2025	→
11/6/24	Q4 FY2024	→
↓

News (8-K)

62 shown

Filed	Type	Description
3/3/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/14/26	Reg FD	Regulation FD Disclosure	→
1/12/26	Reg FD	Regulation FD Disclosure	→
12/12/25	Reg FD	Regulation FD Disclosure	→
11/12/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/11/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

22 shown

Filed	Form	Description
3/20/26	ARS	ARS	→
8/7/25	S-3	S-3	→
3/24/25	424B3	424B3	→
3/21/25	ARS	ARS	→
3/4/25	424B3	424B3	→
12/4/24	424B3	424B3	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

ARS

Mar 20, 2026

0001367644-26-000035ARS

Dec 31, 2025

47.2 MB

DEFA14A

Mar 20, 2026

0001367644-26-000034DEFA14A

—

320.9 KB

DEF 14A

Mar 20, 2026

0001367644-26-000033DEF 14A

Dec 31, 2025

7.9 MB

Mar 6, 2026

0001196632-26-000011FORM 4

May 7, 2025

7.6 KB

Mar 5, 2026

0001242215-26-000008FORM 4

Mar 3, 2026

6.7 KB

Mar 5, 2026

0001190344-26-000010FORM 4

Mar 3, 2026

4.8 KB

Mar 5, 2026

0001190344-26-000008FORM 3

Mar 1, 2026

3.5 KB

Mar 5, 2026

0002044279-26-000003FORM 4

Mar 3, 2026

6.6 KB

Mar 5, 2026

0001989644-26-000005FORM 4

Mar 3, 2026

6.7 KB

Mar 5, 2026

0002043716-26-000005FORM 4

Mar 3, 2026

6.7 KB

Mar 5, 2026

0001961994-26-000009FORM 4

Mar 3, 2026

6.7 KB

Mar 5, 2026

0001196632-26-000009FORM 4

Mar 3, 2026

6.7 KB

Mar 5, 2026

0001919170-26-000009FORM 4

Mar 3, 2026

6.7 KB

Mar 3, 2026

0001961994-26-000006FORM 4

Mar 1, 2026

4.7 KB

Mar 3, 2026

0001196632-26-000006FORM 4

Mar 1, 2026

4.7 KB

Mar 3, 2026

0001919170-26-000006FORM 4

Mar 1, 2026

4.7 KB

8-K

Mar 3, 2026

0001367644-26-0000198-K

Feb 25, 2026

207.7 KB

10-K

Feb 27, 2026

0001367644-26-00001510-K

Dec 31, 2025

20.0 MB

8-K

Feb 26, 2026

0001367644-26-0000128-K

Feb 26, 2026

6.9 MB

Feb 10, 2026

0002043716-26-000002FORM 4

Feb 9, 2026

4.5 KB

Feb 10, 2026

0001919170-26-000003FORM 4

Feb 6, 2026

6.7 KB

Feb 10, 2026

0001961994-26-000003FORM 4

Feb 6, 2026

6.7 KB

Feb 10, 2026

0001989644-26-000002FORM 4

Feb 6, 2026

6.7 KB

Feb 10, 2026

0001196632-26-000003FORM 4

Feb 6, 2026

6.7 KB

SCHEDULE 13G

Feb 9, 2026

0000093751-26-000044

—

7.7 KB

25 filings shown

Filed	Form	Description
2/9/26	SCHEDULE 13G	SCHEDULE 13G	→
1/30/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/7/26	144	144	→
12/22/25	144	144	→
12/5/25	144	144	→
11/10/25	144	144	→
↓

Emergent BioSolutions Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/5/26	4	4	→
3/5/26	4	4	→
3/5/26	3	FORM 3	→
3/5/26	4	4	→
3/5/26	4	4	→
↓